Decreased expression of LATS1 is correlated with the progression and prognosis of glioma

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Ji, Tianhai ^a,b   Liu, Dan ^b   Shao, Wei ^b   Yang, Wensheng ^b   Wu, Haiqiao ^b   Bian, Xiuwu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

CCNA1; LATS1; Prognosis; Tumor suppressor

Indexed keywords

MESSENGER RNA; PROTEIN LATS1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR GROWTH;

ADULT; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES;

EID: 84865285885     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-67     Document Type: Article

References (25)

1. Kleihues P, Cavenee WK, World Health Organization Classification of Tumours-Pathology and Genetics -Tumors of the Nervous System. Lyon France: IARC Press 2000 9 52
2. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G, J Cell Biochem 2008 103 245 255 10.1002/jcb.21400 17549698
3. The 2007 WHO classification of tumours of the central nervous system. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P, Acta Neuropathol 2007 114 97 109 10.1007/s00401-007-0243-4 17618441 (Pubitemid 47103521)
4. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ, Genes Dev 1995 9 534 546 10.1101/gad.9.5.534 7698644
5. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Xu T, Wang W, Zhang S, Stewart RA, Yu W, Development 1995 121 1053 1063 7743921
6. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W, Xu T, Nat Genet 1999 21 177 181 10.1038/5960 9988268 (Pubitemid 29070362)
7. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T, Nat Genet 1999 21 182 186 10.1038/5965 9988269 (Pubitemid 29070363)
8. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Cooke IE, Shelling AN, Le Meuth VG, Charnock ML, Ganesan TS, Genes Chromosomes Cancer 1996 15 223 233 10.1002/(SICI)1098- 2264(199604)15:4<223::AID-GCC4>3.0.CO;2-3 8703848 (Pubitemid 26115930)
9. High resolution mapping of chromosome 6 deletions in cervical cancer. Mazurenko N, Attaleb M, Gritsko T, Semjonova L, Pavlova L, Sakharova O, Kisseljov F, Oncol Rep 1999 6 859 863 10373671
10. Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Fujii H, Zhou W, Gabrielson E, Genes Chromosomes Cancer 1996 16 35 39 10.1002/(SICI)1098-2264(199605)16:1<35::AID-GCC5>3.0.CO;2-4 9162195 (Pubitemid 26141252)
11. Human homologue of the Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis. Yang X, Li D, Chen W, Xu T, Oncogene 2001 20 6516 6523 10.1038/sj.onc.1204817 11641775 (Pubitemid 32980276)
12. LATS1 tumor suppressor regulates G2/M transition and apoptosis. Xia H, Qi H, Li Y, Pei J, Barton J, Blackstad M, Xu T, Tao W, Oncogene 2002 21 1233 1241 10.1038/sj.onc.1205174 11850843 (Pubitemid 34185240)
13. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S, Clin Cancer Res 2005 11 1380 1385 10.1158/1078-0432.CCR-04- 1773 15746036 (Pubitemid 40315216)
14. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Jiang Z, Li X, Hu J, Zhou W, Jiang Y, Li G, Lu D, Neurosci Res 2006 56 450 458 10.1016/j.neures.2006.09.006 17049657 (Pubitemid 44750270)
15. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Liu Z, Li X, He X, Jiang Q, Xie S, Yu X, Zhen Y, Xiao G, Yao K, Fang W, Int J Cancer. Int J Cancer 2011 128 2562 2571
16. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
17. New treatment strategies for malignant gliomas. Avgeropoulos NG, Batchelor TT, Oncologist 1999 4 209 224 10394589 (Pubitemid 29297484)
18. LATS tumor suppressor: a new governor of cellular homeostasis. Visser S, Yang X, Cell Cycle 2010 9 3892 3903 10.4161/cc.9.19.13386 20935475
19. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Zhang J, Smolen GA, Haber DA, Cancer Res 2008 68 2789 2794 10.1158/0008-5472.CAN-07-6205 18413746 (Pubitemid 351556277)
20. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Iida S, Hirota T, Morisaki T, et al. Oncogene 2004 23 5266 5274 10.1038/sj.onc.1207623 15122335 (Pubitemid 39005802)
21. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray. Visser S, Yang X, Gene 2010 449 22 29 10.1016/j.gene.2009.09.008 19799973
22. A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice. Liu D, Liao C, Wolgemuth DJ, Dev Biol 2000 224 388 400 10.1006/dbio.2000.9776 10926775 (Pubitemid 30661019)
23. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex. Diederichs S, Bäumer N, Ji P, Metzelder SK, Idos GE, Cauvet T, Wang W, Möller M, Pierschalski S, Gromoll J, Schrader MG, Koeffler HP, Berdel WE, Serve H, Müller-Tidow C, J Biol Chem 2004 279 33727 33741 10.1074/jbc.M401708200 15159402 (Pubitemid 39063022)
24. Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA. Cho NH, Choi YP, Moon DS, Kim H, Kang S, Ding O, Rha SY, Yang YJ, Cho SH, Cancer Sci 2006 97 1082 1092 10.1111/j.1349-7006.2006. 00292.x 16984381 (Pubitemid 44322558)
25. 17-Estradiol regulates cyclin A1 and cyclin B1 gene expression in adult rat seminiferous tubules. Bois C, Delalande C, Bourama-Lelong H, Durand P, Carreau S, J Mol Endocrinol 2012 48 89 97 10.1530/JME-11-0105 22180637